Cite
HARVARD Citation
Lee, Y. et al. (2018). TP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy. Tumor biology. 40 (8), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, Y. et al. (2018). TP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy. Tumor biology. 40 (8), p. . [Online].